ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 625350 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 625350; 2) Community: the network communities that were significantly associated with the response to NSC 625350; 3) Molecule: the relationships between components within communities and NSC 625350; 4) MDR: the compounds that were significantly associated with the NSC 625350.

NSC Compound Enrichment Correlation
NSC 704565 Null 0.0268790882218883 -0.52093461
NSC 710204 Null 0.0268790882218883 -0.31771185
NSC 725671 5,6-Dihydro-5,11-dioxo-6-(3-amino-1-propyl)-11H-indeno[1,2-c ]isoquinoline hydrochloride 0.0268790882218883 -0.23186075
NSC 740510 6-(11-aminoundecyl)-5,6-dihydro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride 0.0268790882218883 -0.26763935
NSC 746087 1-(7-Fluoro-3-methyl-quinoxalin-2-yl)-3-(3,4,5-trimethoxy-phenyl)-propenone 0.0268790882218883 -0.29836091
NSC 758662 Lovastatin [USAN] 0.0268790882218883 0.34312045
NSC 76779 Streptorubrin 0.0268790882218883 -0.32411035
NSC 625544 Null 0.0285477013888568 -0.37362835
NSC 626879 Cyclopentanone, 2-[(dimethylamino)methyl]-5-heptylidene-, hydrochloride 0.0285477013888568 -0.44517562
NSC 639501 Cyclopentanone, 2-pentylidene-5-[(1-piperidinyl)methyl]- hydrochloride 0.0285477013888568 -0.31043913
Total:60  Current:37    [First] [Prev] [Next] [Last]